MiMedx is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. A pioneer in placental biologics, our core business focuses on the needs of patients with acute and chronic non-healing wounds. www.mimedx.com.